Searched for: in-biosketch:true
person:belmom01
LUPUS PSYCHOSIS AND ANTI-RIBOSOMAL-P PROTEIN ANTIBODIES [Letter]
Belmont, HM; Abramson, S
ISI:A1988L923100024
ISSN: 0028-4793
CID: 31551
Complement activation and vascular injury in systemic lupus erythematosus
Abramson S; Belmont HM; Hopkins P; Buyon J; Winchester R; Weissmann G
The deposition of immune complexes within blood vessel walls results in the potential for complement activation and the release of chemotactic factors, such as fragments of C5 (C5fr). The generation of C5fr results in the intravascular aggregation of neutrophils with subsequent leukostatic occlusion of the pulmonary arterioles. The generation of C5fr may contribute to the pathogenesis of adult respiratory distress syndrome and other diseases. Studies were undertaken to determine the role of circulating complement derived peptides and intravascular neutrophil activation in systemic lupus erythematosus
PMID: 2886660
ISSN: 0380-0903
CID: 59685
Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease
Belmont HM; Hopkins P; Edelson HS; Kaplan HB; Ludewig R; Weissmann G; Abramson S
To determine whether activated complement components appear in the circulation of patients with systemic lupus erythematosus (SLE), we measured C5a and C3a by radioimmunoassay. Mean C5a concentration in the plasma of acutely ill SLE patients was 46.0 ng/ml, compared with 17.1 ng/ml in normal controls (P less than 0.01). Mean C3a concentration in patients with severe disease was 526 ng/ml, compared with 134 ng/ml in controls (P less than 0.01). In patients with moderately active SLE, the mean C3a concentration, but not the mean C5a concentration, was also elevated. In addition, C3a was elevated in 15 or 21 patients with active SLE, whereas low levels of C3 or C4 were noted in only 7 of these 21 patients. We conclude that the measurement of complement-derived anaphylatoxins may be useful in the management of patients with SLE. In addition, we suggest that these circulating mediators may contribute to the pathogenesis of vascular injury in patients with the disease
PMID: 3489467
ISSN: 0004-3591
CID: 59691
PLASMA ANAPHYLATOXIN-C3A PREDICTS LUPUS FLARE AND SIGNALS COMPLEMENT ACTIVATION IN PREGNANT LUPUS PATIENTS [Meeting Abstract]
HOPKINS PT; BELMONT HM; BUYON J; et al.
ISI:A1986C539802049
ISSN: 0009-9279
CID: 51173
LUPUS CRISIS - C3A DESARG AND LIPOXYGENASE PRODUCTS APPEAR IN PLASMA [Meeting Abstract]
Abramson, S; Belmont, HM; Ludewig, R; Kimmel, S; Haines, K; Weissmann, G
ISI:A1985AEY9302065
ISSN: 0009-9279
CID: 30925